The global esophagoscopes & gastroscopes market is estimated to be valued at USD 1,376.9 million in 2025 and is projected to reach USD 2,350.9 million by 2035, registering a CAGR of 5.5% over the ...

AbbVie has announced a definitive agreement to acquire Capstan Therapeutics, a clinical-stage biotechnology company, for up ...

NHS introduces 'innovator passport' to streamline medical tech adoption, reducing bureaucracy and ensuring equitable patient ...

IntroductionIf you’re detail-oriented and enjoy working with scientific equipment, a career as a Lab Technician could be the ...

The announcement of a Life Science Strategy from the European Commission [2 July] includes action to address long-standing ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva ...

BRUSSELS, BE / ACCESS Newswire / July 3, 2025 / Brussels transformed into a Champions League pitch for tobacco harm reduction as the World Vapers' Alliance (WVA) honoured Sweden, the Czech Republic, ...

VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...

SAN FRANCISCO, CA / ACCESS Newswire / July 2, 2025 / The Bay Area CBT Center has unveiled a groundbreaking offering: fully ...

Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ...

STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve ...

Aurobindo Pharma’s Dazublys, a trastuzumab biosimilar for HER2-positive cancers, gains EU approval, enhancing access to ...